# Chromium Succinate

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chromium-succinate
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Chromium(III) succinate, Trivalent chromium succinate, Chromium succinate complex, Cr(III) succinate, Chelated chromium succinate

## Overview

Chromium succinate is a coordination complex pairing trivalent chromium (Cr³⁺) with succinic acid, designed to enhance mineral bioavailability compared to inorganic chromium salts. It is theorized to support insulin receptor signaling and glucose transporter activity, though direct clinical evidence specific to this chelated form remains limited.

## Health Benefits

• Limited research available - no clinical trials specifically on chromium succinate were identified in available sources
• General chromium supplementation has been studied for [glucose metabolism](/ingredients/condition/weight-management) (evidence quality: not specified for succinate form)
• Potential benefits extrapolated from other Cr(III) forms but not clinically validated for succinate
• No meta-analyses or RCTs documented for this specific form
• Safety profile uncertain due to potential ligand-exchange reactions in Cr(III) complexes

## Mechanism of Action

Chromium succinate delivers Cr³⁺ ions that are proposed to potentiate insulin receptor tyrosine kinase activity, enhancing downstream phosphorylation of IRS-1 (insulin receptor substrate-1) and facilitating GLUT4 transporter translocation to cell membranes. The succinate ligand may improve intestinal absorption by protecting chromium from premature oxidation and reducing competition with other minerals in the gut lumen. Chromium is also implicated in the activation of chromodulin (low-molecular-weight chromium-binding substance), an oligopeptide that amplifies insulin receptor sensitivity in hepatic and skeletal muscle cells.

## Clinical Summary

No published randomized controlled trials have specifically examined chromium succinate as an isolated intervention in human subjects, representing a critical gap in the evidence base. Extrapolation from chromium picolinate and chromium polynicotinate studies — which typically enrolled 30–200 participants over 8–16 weeks — suggests modest reductions in fasting [blood glucose](/ingredients/condition/weight-management) (approximately 10–15 mg/dL in insulin-resistant populations) and minor improvements in HbA1c. A 2004 meta-analysis by Althuis et al. in the American Journal of Clinical Nutrition found that chromium supplementation broadly produced inconsistent glucose outcomes, with effect sizes varying substantially by form and baseline glycemic status. Until form-specific trials on chromium succinate are conducted, efficacy claims for this compound remain extrapolated and unverified.

## Nutritional Profile

Chromium Succinate is an inorganic-organic coordination compound consisting of trivalent chromium [Cr(III)] chelated with succinic acid (butanedioic acid). It is not a whole food ingredient and therefore contains no macronutrients (protein, fat, carbohydrates), dietary fiber, or caloric value in supplemental doses. Micronutrient content is defined solely by its elemental chromium contribution: typical supplemental doses range from 200–1000 mcg elemental chromium per day, with chromium comprising approximately 15–20% of the molecular weight of the chromium succinate complex (exact percentage depends on coordination stoichiometry, typically Cr(III) bound to one or two succinate ligands). The succinate moiety (C4H4O4²⁻) is a four-carbon dicarboxylate that also serves as an endogenous intermediate in the citric acid (Krebs) cycle, potentially contributing minimally to mitochondrial [energy metabolism](/ingredients/condition/energy) at supplemental doses, though this contribution is nutritionally negligible. Bioavailability: Cr(III) forms in general have low oral bioavailability, estimated at 0.4–2.5% absorption for inorganic chromium salts; organic chelates such as chromium picolinate and chromium nicotinate have demonstrated modestly improved absorption (2–3%) compared to chromium chloride. Chromium succinate's specific bioavailability has not been formally quantified in published human pharmacokinetic studies, but the organic chelation is hypothesized to enhance mucosal uptake relative to chromium chloride by protecting Cr(III) from forming insoluble hydroxides in the alkaline intestinal environment. No vitamins, fiber, or additional bioactive compounds are present beyond the chromium and succinate constituents.

## Dosage & Preparation

No clinically studied dosage ranges are available for chromium succinate specifically. General nutritional chromium intake is around 20-35 mcg/day for adults, but no standardized succinate dosing data is documented. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Chromium succinate is generally regarded as low-risk at typical supplemental doses of 200–1000 mcg elemental chromium per day, consistent with tolerable upper intake patterns observed for other trivalent chromium forms, though no form-specific toxicity threshold has been established for the succinate chelate. High-dose chromium supplementation has been associated with rare reports of renal impairment, hepatotoxicity, and rhabdomyolysis, primarily from case reports involving chromium picolinate at supraphysiological doses. Chromium may potentiate the effects of insulin and oral hypoglycemic agents such as metformin and sulfonylureas, increasing hypoglycemia risk, requiring [blood glucose](/ingredients/condition/weight-management) monitoring. Safety data in pregnancy and lactation are insufficient; use is generally not recommended without medical supervision during these periods.

## Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on chromium succinate were identified in the available sources. Research focuses primarily on elemental chromium or other forms like chromium picolinate, with no PMIDs available for chromium succinate studies.

## Historical & Cultural Context

No historical or traditional medicinal uses are documented for chromium succinate in any traditional medicine systems including Ayurveda or TCM. Chromium as an element has no noted traditional context in available sources.

## Synergistic Combinations

Insufficient data - no synergistic ingredients documented for chromium succinate

## Frequently Asked Questions

### What is chromium succinate used for?

Chromium succinate is primarily used as a dietary supplement intended to support blood glucose regulation and insulin sensitivity by delivering bioavailable Cr³⁺ ions. It is marketed as a chelated alternative to inorganic chromium salts, with succinic acid serving as the ligand to potentially improve gastrointestinal absorption. Its use is most common among individuals managing insulin resistance or type 2 diabetes, though direct clinical evidence for this specific form is lacking.

### Is chromium succinate better absorbed than chromium picolinate?

There are no published head-to-head human bioavailability trials directly comparing chromium succinate to chromium picolinate. Chromium picolinate has documented absorption advantages over inorganic chromium chloride, with urinary chromium excretion studies suggesting roughly 1.2–2% absorption rates. Whether the succinate chelate confers superior, equivalent, or inferior bioavailability to picolinate remains an open research question with no definitive answer currently available.

### What is the recommended dosage for chromium succinate?

No dosage specific to chromium succinate has been established in clinical guidelines, as no trials have defined an effective dose for this particular form. General chromium supplementation research has used elemental chromium doses ranging from 200 to 1000 mcg per day, with most glucose metabolism studies clustering around 400–600 mcg elemental chromium daily. The actual elemental chromium content per capsule of chromium succinate depends on the chelation ratio and product formulation, so label verification is essential.

### Can chromium succinate lower blood sugar?

Chromium succinate has not been studied in isolation for blood sugar lowering in human clinical trials. Evidence from related chromium forms suggests modest hypoglycemic effects in individuals with impaired glucose tolerance or type 2 diabetes, with some studies reporting fasting glucose reductions of 8–15 mg/dL and small HbA1c improvements of 0.3–0.5% over 12–16 weeks. These outcomes should not be assumed to apply directly to chromium succinate without form-specific research.

### Does chromium succinate interact with diabetes medications?

Chromium, including in chelated forms like chromium succinate, may have additive blood glucose-lowering effects when combined with insulin, metformin, sulfonylureas (e.g., glipizide, glibenclamide), or thiazolidinediones (e.g., pioglitazone), potentially increasing hypoglycemia risk. Patients on any antidiabetic pharmacotherapy should monitor blood glucose more frequently when introducing chromium supplementation and consult a healthcare provider for dose adjustments. No chromium succinate-specific drug interaction studies have been published to date.

### What does the research evidence show about chromium succinate's effectiveness?

Currently, there are no published clinical trials or meta-analyses specifically studying chromium succinate as a standalone ingredient, which limits the strength of evidence available for this form. Most research on chromium's effects on glucose metabolism has been conducted using other chromium forms such as picolinate or polynicotinate, so benefits cannot be definitively confirmed for the succinate form. The existing evidence for chromium succinate relies on theoretical extrapolation from general chromium(III) research rather than direct clinical validation. More rigorous human studies would be needed to establish the efficacy and safety profile specific to this ingredient.

### Who is most likely to benefit from chromium succinate supplementation?

While general chromium supplementation has been studied in people with blood sugar regulation concerns and metabolic health issues, there is no clinical data identifying which populations would specifically benefit from chromium succinate. Individuals interested in chromium for metabolic support may consider this form, but they should consult a healthcare provider to determine if supplementation is appropriate for their individual health status. People with prediabetes or diabetes seeking chromium supplementation should work with their doctor to evaluate whether any chromium form is suitable for their treatment plan. The lack of specific research on chromium succinate means personalized medical guidance is particularly important before use.

### Are there any known side effects or safety concerns unique to chromium succinate?

No adverse events have been specifically documented for chromium succinate in available literature, though this reflects limited research rather than proven safety. General chromium supplementation at appropriate doses is typically considered safe in the general population, but the succinate form has not been formally evaluated for tolerability in clinical trials. Safety data regarding use in special populations such as pregnant women, nursing mothers, or those with kidney or liver disease are not available for this specific form. Anyone with health concerns or taking medications should consult a healthcare provider before using chromium succinate supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*